In landslide vote, Senate boosts Biden’s moonshot, weakens FDA drug testing

Enlarge / Vice President Joe Biden stops to speak with reporters in the Senate Reception Room following the cloture vote on the “21st Century Cures Act” in the Capitol on Monday, December 5, 2016. (credit: Getty | Bill Clark)

Today, Senators overwhelmingly passed the massive 21st Century Cures Act with a 94-to-5 vote.

The $6.3 billion, nearly 1,000-page (PDF) health legislation has been in the works since 2014 and spans far-flung issues. One of the bill’s central and most controversial aims is to relax and accelerate the Food and Drug Administration’s drug approval process, which backers argue will usher new, life-saving treatments to patients faster. The bill is also designed to simplify research grants and policy, make mental health a national priority, bolster monitoring of drug-resistant bacteria, provide states with funding to fight the opioid crisis, and support three Obama-era research initiatives, including Vice President Biden’s cancer moonshot.

If it sounds like the bill has been carefully crafted to have a little something for everyone, that’s because it has. The 21st Century Cures Act was the most heavily lobbied health care bill in recent history, according to Kaiser Health News. More than 1,455 lobbyists representing 400 companies and organizations were involved—that’s nearly three lobbyists for every one Congress member.

Read 9 remaining paragraphs | Comments



Source: Ars Technica – In landslide vote, Senate boosts Biden’s moonshot, weakens FDA drug testing